{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Notice\" and posted_year = 2026 sorted by posted_date descending", "rows": [["FDA-2023-N-0119-0020", "FDA", "FDA-2023-N-0119", "Fiscal Year 2026 Generic Drug Science and Research Initiatives Workshop; Public Workshop; Request for\nComments", "Notice", "Request for Comments", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-07-11T03:59:59Z", "2026-02-27T19:57:39Z", "2026-03961", 1, 0, "09000064b91e326c"], ["FDA-2007-D-0369-2428", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability", "Notice", "Notice of Availability", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", null, "2026-02-27T19:14:17Z", "2026-03963", 0, 0, "09000064b91e3271"], ["FDA-1991-N-0191-0010", "FDA", "FDA-1991-N-0191", "Civil Money Penalties; Biologics, Drugs, and Medical Devices; Extension of Comment Period; Correction and Addition\nPeriod; Correction and Addition", "Notice", "Notice of Extension", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "1993-08-26T03:59:59Z", "2026-02-28T02:00:09Z", "93-17833", 0, 0, "090000648052deaf"], ["FDA-2026-N-1486-0001", "FDA", "FDA-2026-N-1486", "Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ZYCUBO (Copper Histidinate)", "Notice", "Announcement", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", null, "2026-02-27T20:11:11Z", "2026-03925", 0, 0, "09000064b91e323b"], ["FDA-2026-N-1628-0001", "FDA", "FDA-2026-N-1628", "International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Scheduling Recommendations; N-Pyrrolidino Isotonitazene; N-Desethyl Etonitazene; Coca Leaf; MDMB-FUBINACA; Request for Comments", "Notice", "Request for Comments", "2026-02-27T05:00:00Z", 2026, 2, "2026-02-27T05:00:00Z", "2026-03-06T04:59:59Z", "2026-02-27T20:18:13Z", "2026-03914", 1, 0, "09000064b91e31af"], ["FDA-2024-E-3572-0007", "FDA", "FDA-2024-E-3572", "Determination of Regulatory Review Period for Purposes of Patent Extension; TEVIMBRA", "Notice", "Determinations", "2026-02-26T05:00:00Z", 2026, 2, "2026-02-26T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-26T20:52:55Z", "2026-03851", 1, 0, "09000064b91deb48"], ["FDA-2025-E-0161-0006", "FDA", "FDA-2025-E-0161", "Determination of Regulatory Review Period for Purposes of Patent Extension; ORLYNVAH", "Notice", "Determinations", "2026-02-26T05:00:00Z", 2026, 2, "2026-02-26T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-26T20:55:38Z", "2026-03848", 1, 0, "09000064b91deb09"], ["FDA-2024-E-3565-0006", "FDA", "FDA-2024-E-3565", "Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM", "Notice", "Determinations", "2026-02-26T05:00:00Z", 2026, 2, "2026-02-26T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-26T20:38:14Z", "2026-03855", 1, 0, "09000064b91e03ee"], ["FDA-2024-E-3555-0007", "FDA", "FDA-2024-E-3555", "Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM", "Notice", "Determinations", "2026-02-26T05:00:00Z", 2026, 2, "2026-02-26T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-26T20:35:08Z", "2026-03855", 1, 0, "09000064b91dec48"], ["FDA-2025-N-2549-0004", "FDA", "FDA-2025-N-2549", "Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational Device Exemptions Reports and Records", "Notice", "30 Day Proposed Information Collection", "2026-02-26T05:00:00Z", 2026, 2, "2026-02-26T05:00:00Z", "2026-03-31T03:59:59Z", "2026-02-26T20:50:21Z", "2026-03857", 1, 0, "09000064b91dec05"], ["FDA-2025-E-1226-0007", "FDA", "FDA-2025-E-1226", "Determination of Regulatory Review Period for Purposes of Patent Extension; AEROPACE", "Notice", "Determinations", "2026-02-26T05:00:00Z", 2026, 2, "2026-02-26T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-26T20:32:36Z", "2026-03849", 1, 0, "09000064b91dec81"], ["FDA-2025-E-1229-0006", "FDA", "FDA-2025-E-1229", "Determination of Regulatory Review Period for Purposes of Patent Extension; MERIT MEDICAL WRAPSODY", "Notice", "Determinations", "2026-02-26T05:00:00Z", 2026, 2, "2026-02-26T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-26T20:43:12Z", "2026-03853", 1, 0, "09000064b91e03f1"], ["FDA-2025-E-0371-0006", "FDA", "FDA-2025-E-0371", "Determination of Regulatory Review Period for Purposes of Patent Extension; REVUFORJ", "Notice", "Determinations", "2026-02-26T05:00:00Z", 2026, 2, "2026-02-26T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-26T20:46:51Z", "2026-03847", 1, 0, "09000064b91dec08"], ["FDA-2024-E-3564-0006", "FDA", "FDA-2024-E-3564", "Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM", "Notice", "Determinations", "2026-02-26T05:00:00Z", 2026, 2, "2026-02-26T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-26T20:36:56Z", "2026-03855", 1, 0, "09000064b91e03ed"], ["FDA-2025-E-0500-0006", "FDA", "FDA-2025-E-0500", "Determination of Regulatory Review Period for Purposes of Patent Extension; TRYNGOLZA", "Notice", "Determinations", "2026-02-26T05:00:00Z", 2026, 2, "2026-02-26T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-26T20:57:25Z", "2026-03850", 1, 0, "09000064b91deac5"], ["FDA-2025-E-1228-0006", "FDA", "FDA-2025-E-1228", "Determination of Regulatory Review Period for Purposes of Patent Extension; MERIT MEDICAL WRAPSODY", "Notice", "Determinations", "2026-02-26T05:00:00Z", 2026, 2, "2026-02-26T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-27T10:00:26Z", "2026-03853", 1, 0, "09000064b91dec45"], ["FDA-2025-N-0195-0003", "FDA", "FDA-2025-N-0195", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", null, "2026-02-25T18:43:32Z", "2026-03774", 0, 0, "09000064b91da9f5"], ["FDA-2011-N-0179-0041", "FDA", "FDA-2011-N-0179", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", null, "2026-02-25T18:54:39Z", "2026-03774", 0, 0, "09000064b91da06e"], ["FDA-2025-N-0339-0005", "FDA", "FDA-2025-N-0339", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", null, "2026-02-25T18:48:04Z", "2026-03774", 0, 0, "09000064b91da190"], ["FDA-2010-D-0350-0035", "FDA", "FDA-2010-D-0350", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Tobacco Retailer Training Programs", "Notice", "30 Day Proposed Information Collection", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", "2026-03-28T03:59:59Z", "2026-02-25T21:05:09Z", "2026-03771", 1, 0, "09000064b91d5d25"], ["FDA-2024-N-5579-0004", "FDA", "FDA-2024-N-5579", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", null, "2026-02-25T18:45:07Z", "2026-03774", 0, 0, "09000064b91daa30"], ["FDA-2025-N-0734-0004", "FDA", "FDA-2025-N-0734", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", null, "2026-02-25T18:41:54Z", "2026-03774", 0, 0, "09000064b91da9f4"], ["FDA-2025-N-0418-0006", "FDA", "FDA-2025-N-0418", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", null, "2026-02-25T18:49:26Z", "2026-03774", 0, 0, "09000064b91da191"], ["FDA-2026-D-1256-0001", "FDA", "FDA-2026-D-1256", "Considerations for the Use of the Plausible Mechanism Framework To Develop Individualized Therapies That Target Specific Genetic Conditions With Known Biological Cause; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", null, "2026-02-25T19:04:38Z", "2026-03713", 0, 0, "09000064b91da53f"], ["FDA-2026-N-0027-0001", "FDA", "FDA-2026-N-0027", "Agency Information Collection Activities; Proposed Collection; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing", "Notice", "60 Day Proposed Information Collection", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-25T19:16:33Z", "2026-03773", 1, 0, "09000064b91da53a"], ["FDA-2025-N-0373-0005", "FDA", "FDA-2025-N-0373", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", null, "2026-02-25T18:38:37Z", "2026-03774", 0, 0, "09000064b91da9f3"], ["FDA-2025-N-0706-0004", "FDA", "FDA-2025-N-0706", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", null, "2026-02-25T18:35:42Z", "2026-03774", 0, 0, "09000064b91da698"], ["FDA-2024-N-5944-0005", "FDA", "FDA-2024-N-5944", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", null, "2026-02-25T18:46:30Z", "2026-03774", 0, 0, "09000064b91da18f"], ["FDA-2026-N-0496-0001", "FDA", "FDA-2026-N-0496", "Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds", "Notice", "60 Day Proposed Information Collection", "2026-02-25T05:00:00Z", 2026, 2, "2026-02-25T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-25T18:59:39Z", "2026-03772", 1, 0, "09000064b91da591"], ["FDA-2026-N-0686-0001", "FDA", "FDA-2026-N-0686", "Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements", "Notice", "60 Day Proposed Information Collection", "2026-02-24T05:00:00Z", 2026, 2, "2026-02-24T05:00:00Z", "2026-04-28T03:59:59Z", "2026-02-24T19:45:30Z", "2026-03589", 1, 0, "09000064b91d5809"], ["FDA-2026-N-0008-0001", "FDA", "FDA-2026-N-0008", "Advisory Committee; Gastrointestinal Drugs Advisory Committee; Renewal", "Notice", "Notice of Renewal", "2026-02-24T05:00:00Z", 2026, 2, "2026-02-24T05:00:00Z", null, "2026-02-24T20:00:59Z", "2026-03587", 0, 0, "09000064b91d5691"], ["FDA-2025-N-4348-0007", "FDA", "FDA-2025-N-4348", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act", "Notice", "30 Day Proposed Information Collection", "2026-02-23T05:00:00Z", 2026, 2, "2026-02-23T05:00:00Z", "2026-03-26T03:59:59Z", "2026-02-23T19:24:04Z", "2026-03448", 1, 0, "09000064b91d0371"], ["FDA-2025-P-1808-0004", "FDA", "FDA-2025-P-1808", "Determination That Klonopin (Clonazepam) Tablets, 0.125 Milligrams and 0.25 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2026-02-23T05:00:00Z", 2026, 2, null, null, "2026-02-23T19:17:58Z", "2026-03495", 0, 0, "09000064b91d0373"], ["FDA-2026-N-0672-0001", "FDA", "FDA-2026-N-0672", "Issuance of Priority Review Voucher; Rare Pediatric Disease Product; WASKYRA (etuvetidigene autotemcel)", "Notice", "Announcement", "2026-02-23T05:00:00Z", 2026, 2, null, null, "2026-02-23T19:28:45Z", "2026-03493", 0, 0, "09000064b91d029d"], ["FDA-2024-N-1939-0023", "FDA", "FDA-2024-N-1939", "Requirements for Additional Traceability Records for Certain Foods; Exemption for Cottage Cheese\nRegulated by the National Conference on Interstate Milk Shipments Grade \u2018\u2018A\u2019\u2019 Pasteurized Milk Ordinance", "Notice", "Announcement", "2026-02-20T05:00:00Z", 2026, 2, "2026-02-20T05:00:00Z", null, "2026-02-20T19:57:25Z", "2026-03362", 0, 0, "09000064b91c75b3"], ["FDA-2026-N-0746-0001", "FDA", "FDA-2026-N-0746", "Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for\nFinished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing\nTechnologies Designation Program", "Notice", "60 Day Proposed Information Collection", "2026-02-20T05:00:00Z", 2026, 2, "2026-02-20T05:00:00Z", "2026-04-22T03:59:59Z", "2026-02-21T10:00:24Z", "2026-03326", 1, 0, "09000064b91c75af"], ["FDA-2026-N-1224-0001", "FDA", "FDA-2026-N-1224", "Masuu Global Solutions LLC, U.S. Agent for Extrovis AG, et al.; Withdrawal of Approval of 11 Abbreviated New Drug Applications", "Notice", "Withdrawal", "2026-02-20T05:00:00Z", 2026, 2, "2026-02-20T05:00:00Z", null, "2026-02-20T20:33:28Z", "2026-03411", 0, 0, "09000064b91c30c7"], ["FDA-2026-N-1305-0001", "FDA", "FDA-2026-N-1305", "Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drugs for Minor Use and Minor Species", "Notice", "60 Day Proposed Information Collection", "2026-02-20T05:00:00Z", 2026, 2, "2026-02-20T05:00:00Z", "2026-04-22T03:59:59Z", "2026-02-20T20:30:11Z", "2026-03353", 1, 0, "09000064b91c750d"], ["FDA-2025-D-2837-0001", "FDA", "FDA-2025-D-2837", "Questions and Answers About Requirements for Additional Traceability Records for Certain Foods; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2026-02-20T05:00:00Z", 2026, 2, "2026-02-20T05:00:00Z", null, "2026-02-20T20:36:36Z", "2026-03363", 0, 0, "09000064b91c3081"], ["FDA-2026-N-0499-0001", "FDA", "FDA-2026-N-0499", "Agency Information Collection Activities; Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice", "Notice", "60 Day Proposed Information Collection", "2026-02-20T05:00:00Z", 2026, 2, "2026-02-20T05:00:00Z", "2026-04-22T03:59:59Z", "2026-02-20T20:23:05Z", "2026-03332", 1, 0, "09000064b91c75b1"], ["FDA-2026-N-0684-0001", "FDA", "FDA-2026-N-0684", "Agency Information Collection Activities; Proposed Collection; Comment Request; Approved Organizations for Wholesale Drug Distributors and Third-Party Logistics Providers", "Notice", "60 Day Proposed Information Collection", "2026-02-20T05:00:00Z", 2026, 2, "2026-02-20T05:00:00Z", "2026-04-22T03:59:59Z", "2026-02-20T20:51:55Z", "2026-03333", 1, 0, "09000064b91c307f"], ["FDA-2025-N-1927-0102", "FDA", "FDA-2025-N-1927", "GRAS Notice (GRN) 1220 - Mycelial biomass from Pleurotus pulmonarius \u2013 amendments", "Notice", "General Notice", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", null, "2026-02-19T18:41:53Z", null, 0, 0, "09000064b91b9273"], ["FDA-2025-N-1928-0048", "FDA", "FDA-2025-N-1928", "GRAS Notice (GRN) 1260 - Rebaudioside M - amendments", "Notice", "General Notice", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", null, "2026-02-19T18:44:51Z", null, 0, 0, "09000064b91b93bd"], ["FDA-2025-N-1928-0051", "FDA", "FDA-2025-N-1928", "GRAS Notice (GRN) 1284 - Recombinant bovine lactoferrin produced by a modified strain of Komagataella phaffii", "Notice", "General Notice", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", null, "2026-02-19T18:46:12Z", null, 0, 0, "09000064b91b93c0"], ["FDA-2004-N-0451-0061", "FDA", "FDA-2004-N-0451", "Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 065", "Notice", "Announcement", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", null, "2026-02-21T03:50:57Z", "2026-03310", 1, 0, "09000064b91bd3d2"], ["FDA-2025-N-0342-0002", "FDA", "FDA-2025-N-0342", "Sherri Insprucker: Final Debarment Order", "Notice", "Statutory Debarment", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", null, "2026-02-23T20:20:09Z", "2026-03254", 1, 0, "09000064b91bd40a"], ["FDA-2025-N-1928-0050", "FDA", "FDA-2025-N-1928", "GRAS Notice (GRN) 1269 - Modified-monellin preparation \u2013 amendments", "Notice", "General Notice", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", null, "2026-02-19T18:45:53Z", null, 0, 0, "09000064b91b93bf"], ["FDA-2025-N-1927-0101", "FDA", "FDA-2025-N-1927", "GRAS Notice (GRN) 1165 - (R)-1,3-Butanediol", "Notice", "General Notice", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", null, "2026-02-19T18:40:51Z", null, 0, 0, "09000064b91b93b8"], ["FDA-2026-N-0498-0001", "FDA", "FDA-2026-N-0498", "Agency Information Collection Activities; Proposed Collection; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products", "Notice", "60 Day Proposed Information Collection", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", "2026-04-21T03:59:59Z", "2026-02-19T20:20:32Z", "2026-03311", 1, 0, "09000064b91bd409"], ["FDA-2025-N-0309-0002", "FDA", "FDA-2025-N-0309", "Sherrie R. McCain: Final Debarment Order", "Notice", "Statutory Debarment", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", null, "2026-02-23T20:20:44Z", "2026-03252", 1, 0, "09000064b91bd493"], ["FDA-2026-N-1309-0001", "FDA", "FDA-2026-N-1309", "Revocation of Authorization of Emergency Use of ExThera Medical Corporation Seraph 100 Microbind Affinity Blood Filter (Seraph 100); Availability", "Notice", "Announcement", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", null, "2026-02-19T20:52:19Z", "2026-03250", 0, 0, "09000064b91bd344"], ["FDA-2025-N-0345-0002", "FDA", "FDA-2025-N-0345", "Justin Insprucker: Final Debarment Order", "Notice", "Statutory Debarment", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", null, "2026-02-21T03:49:27Z", "2026-03253", 1, 0, "09000064b91bd4c5"], ["FDA-2025-N-1928-0049", "FDA", "FDA-2025-N-1928", "GRAS Notice (GRN) 1261 - 2'-Fucosyllactose - amendment", "Notice", "General Notice", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", null, "2026-02-19T18:45:13Z", null, 0, 0, "09000064b91b93be"], ["FDA-2025-E-0862-0006", "FDA", "FDA-2025-E-0862", "Determination of Regulatory Review Period for Purposes of Patent Extension; SYMVESS", "Notice", "Determinations", "2026-02-19T05:00:00Z", 2026, 2, "2026-02-19T05:00:00Z", "2026-04-21T03:59:59Z", "2026-02-19T20:54:45Z", "2026-03312", 1, 0, "09000064b91bd33f"], ["FDA-2025-N-1812-0002", "FDA", "FDA-2025-N-1812", "Agency Information Collection Activities; Proposed Collection; Comment Request; Q-Submission and Early Payor Feedback Request Programs and Medical Device Development Tools", "Notice", "30 Day Proposed Information Collection", "2026-02-18T05:00:00Z", 2026, 2, "2026-02-18T05:00:00Z", "2026-03-21T03:59:59Z", "2026-02-18T18:59:05Z", "2026-03096", 1, 0, "09000064b91b9022"], ["FDA-2024-N-1055-0004", "FDA", "FDA-2024-N-1055", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request Data To Support Social and Behavioral Research as Used by the Food and Drug Administration", "Notice", "30 Day Proposed Information Collection", "2026-02-18T05:00:00Z", 2026, 2, "2026-02-18T05:00:00Z", "2026-03-21T03:59:59Z", "2026-02-18T19:28:44Z", "2026-03099", 1, 0, "09000064b91b8e75"], ["FDA-2025-N-0615-0002", "FDA", "FDA-2025-N-0615", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Generic Clearance for Quick Turnaround Testing of Communication Effectiveness", "Notice", "30 Day Proposed Information Collection", "2026-02-18T05:00:00Z", 2026, 2, "2026-02-18T05:00:00Z", "2026-03-21T03:59:59Z", "2026-02-18T18:51:59Z", "2026-03095", 1, 0, "09000064b91b90b3"], ["FDA-2026-N-0497-0001", "FDA", "FDA-2026-N-0497", "Agency Information Collection Activities; Proposed Collection; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions", "Notice", "60 Day Proposed Information Collection", "2026-02-18T05:00:00Z", 2026, 2, "2026-02-18T05:00:00Z", "2026-04-21T03:59:59Z", "2026-02-18T19:12:13Z", "2026-03094", 1, 0, "09000064b91b8f13"], ["FDA-2026-N-0958-0001", "FDA", "FDA-2026-N-0958", "Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ZEVASKYN (Prademagene Zamikeracel)", "Notice", "Announcement", "2026-02-18T05:00:00Z", 2026, 2, null, null, "2026-02-18T19:14:39Z", "2026-03211", 0, 0, "09000064b91b8ec7"], ["FDA-2025-N-2652-0006", "FDA", "FDA-2025-N-2652", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco To Protect Children and Adolescents", "Notice", "30 Day Proposed Information Collection", "2026-02-18T05:00:00Z", 2026, 2, "2026-02-18T05:00:00Z", "2026-03-21T03:59:59Z", "2026-02-18T19:08:22Z", "2026-03098", 1, 0, "09000064b91b8fa6"], ["FDA-2025-N-1560-0002", "FDA", "FDA-2025-N-1560", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Electronic Products Requirements", "Notice", "30 Day Proposed Information Collection", "2026-02-18T05:00:00Z", 2026, 2, "2026-02-18T05:00:00Z", "2026-03-21T03:59:59Z", "2026-02-18T19:24:09Z", "2026-03097", 1, 0, "09000064b91b8ec4"], ["FDA-2025-N-0308-0003", "FDA", "FDA-2025-N-0308", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Emerging Drug Safety Technology Program", "Notice", "30 Day Proposed Information Collection", "2026-02-18T05:00:00Z", 2026, 2, "2026-02-18T05:00:00Z", "2026-03-21T03:59:59Z", "2026-02-18T18:55:14Z", "2026-03093", 1, 0, "09000064b91b9066"], ["FDA-2025-P-3575-0003", "FDA", "FDA-2025-P-3575", "Determination That TOLECTIN DS (Tolmetin Sodium) Capsule, Equivalent to 400 Milligrams Base, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2026-02-18T05:00:00Z", 2026, 2, null, null, "2026-02-18T19:03:46Z", "2026-03213", 0, 0, "09000064b91b901e"], ["FDA-2025-E-0357-0006", "FDA", "FDA-2025-E-0357", "Determination of Regulatory Review Period for Purposes of Patent Extension; ATTRUBY", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T19:41:11Z", "2026-02971", 1, 0, "09000064b91a9f20"], ["FDA-2025-E-0359-0006", "FDA", "FDA-2025-E-0359", "Determination of Regulatory Review Period for Purposes of Patent Extension; ATTRUBY", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T19:43:37Z", "2026-02971", 1, 0, "09000064b91a9ff7"], ["FDA-2024-E-3532-0006", "FDA", "FDA-2024-E-3532", "Determination of Regulatory Review Period for Purposes of Patent Extension; AMTAGVI", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T19:54:42Z", "2026-02974", 1, 0, "09000064b91aa73f"], ["FDA-2025-E-2426-0006", "FDA", "FDA-2025-E-2426", "Determination of Regulatory Review Period for Purposes of Patent Extension; BLUJEPA", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-08-13T03:59:59Z", "2026-02-13T20:03:13Z", "2026-02901", 1, 0, "09000064b91aa6fb"], ["FDA-2024-E-3876-0006", "FDA", "FDA-2024-E-3876", "Determination of Regulatory Review Period for Purposes of Patent Extension; RYTELO", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-20T20:30:13Z", "2026-02903", 1, 0, "09000064b91a8f34"], ["FDA-2025-E-0483-0006", "FDA", "FDA-2025-E-0483", "Determination of Regulatory Review Period for Purposes of Patent Extension; ALYFTREK", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T19:46:46Z", "2026-02968", 1, 0, "09000064b91aa742"], ["FDA-2025-E-0362-0006", "FDA", "FDA-2025-E-0362", "Determination of Regulatory Review Period for Purposes of Patent Extension; AUCATZYL", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T20:01:58Z", "2026-02972", 1, 0, "09000064b91a9ffe"], ["FDA-2025-E-0370-0006", "FDA", "FDA-2025-E-0370", "Determination of Regulatory Review Period for Purposes of Patent Extension; KEBILIDI", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T20:10:45Z", "2026-02976", 1, 0, "09000064b91a8f35"], ["FDA-2025-E-0361-0006", "FDA", "FDA-2025-E-0361", "Determination of Regulatory Review Period for Purposes of Patent Extension; AUCATZYL", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T20:00:39Z", "2026-02972", 1, 0, "09000064b91aa73c"], ["FDA-2025-E-0360-0006", "FDA", "FDA-2025-E-0360", "Determination of Regulatory Review Period for Purposes of Patent Extension; ATTRUBY", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T19:44:45Z", "2026-02971", 1, 0, "09000064b91a9ff8"], ["FDA-2024-E-3872-0006", "FDA", "FDA-2024-E-3872", "Determination of Regulatory Review Period for Purposes of Patent Extension; RYTELO", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-20T20:30:14Z", "2026-02903", 1, 0, "09000064b91aa6a8"], ["FDA-2024-E-3873-0006", "FDA", "FDA-2024-E-3873", "Determination of Regulatory Review Period for Purposes of Patent Extension; RYTELO", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-20T20:30:13Z", "2026-02903", 1, 0, "09000064b91a6c3d"], ["FDA-2025-E-0492-0006", "FDA", "FDA-2025-E-0492", "Determination of Regulatory Review Period for Purposes of Patent Extension; CRENESSITY", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T19:36:15Z", "2026-02973", 1, 0, "09000064b91a9f1c"], ["FDA-2025-E-0491-0006", "FDA", "FDA-2025-E-0491", "Determination of Regulatory Review Period for Purposes of Patent Extension; CRENESSITY", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T19:34:31Z", "2026-02973", 1, 0, "09000064b91aa8fb"], ["FDA-2025-E-0508-0006", "FDA", "FDA-2025-E-0508", "Determination of Regulatory Review Period for Purposes of Patent Extension; CRENESSITY", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T19:37:35Z", "2026-02973", 1, 0, "09000064b91a9f1e"], ["FDA-2025-E-0358-0006", "FDA", "FDA-2025-E-0358", "Determination of Regulatory Review Period for Purposes of Patent Extension; ATTRUBY", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T19:42:24Z", "2026-02971", 1, 0, "09000064b91a9ff6"], ["FDA-2025-E-0369-0006", "FDA", "FDA-2025-E-0369", "Determination of Regulatory Review Period for Purposes of Patent Extension; KEBILIDI", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T20:09:40Z", "2026-02976", 1, 0, "09000064b91a72ba"], ["FDA-2023-D-2925-4518", "FDA", "FDA-2023-D-2925", "Defining Durations of Use for Approved Medically Important Antimicrobial Drugs Fed to Food-Producing Animals; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2026-02-13T05:00:00Z", 2026, 2, null, null, "2026-02-13T20:12:58Z", "2026-02934", 0, 0, "09000064b91aa7ca"], ["FDA-2024-E-3534-0006", "FDA", "FDA-2024-E-3534", "Determination of Regulatory Review Period for Purposes of Patent Extension; AMTAGVI", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T19:56:16Z", "2026-02974", 1, 0, "09000064b91a9ffc"], ["FDA-2025-E-0355-0006", "FDA", "FDA-2025-E-0355", "Determination of Regulatory Review Period for Purposes of Patent Extension; ATTRUBY", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-13T19:39:29Z", "2026-02971", 1, 0, "09000064b91aa814"], ["FDA-2024-E-3875-0006", "FDA", "FDA-2024-E-3875", "Determination of Regulatory Review Period for Purposes of Patent Extension; RYTELO", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-20T20:30:13Z", "2026-02903", 1, 0, "09000064b91a8f33"], ["FDA-2024-E-3874-0006", "FDA", "FDA-2024-E-3874", "Determination of Regulatory Review Period for Purposes of Patent Extension; RYTELO", "Notice", "Determinations", "2026-02-13T05:00:00Z", 2026, 2, "2026-02-13T05:00:00Z", "2026-04-15T03:59:59Z", "2026-02-20T20:30:13Z", "2026-02903", 1, 0, "09000064b91a8f32"], ["FDA-2025-N-0435-0002", "FDA", "FDA-2025-N-0435", "Jeremy Spencer Brown: Final Debarment Order", "Notice", "Statutory Debarment", "2026-02-12T05:00:00Z", 2026, 2, "2026-02-12T05:00:00Z", null, "2026-02-12T18:22:54Z", "2026-02786", 1, 0, "09000064b91a64fb"], ["FDA-2012-D-1197-0013", "FDA", "FDA-2012-D-1197", "Certification Process for Designated Medical Gases; Draft Guidance for Industry; Availability; Agency\nInformation Collection Activities; Proposed Collection; Comment Request", "Notice", "Notice of Availability", "2026-02-12T05:00:00Z", 2026, 2, "2026-02-12T05:00:00Z", null, "2026-02-12T18:33:11Z", "2026-02789", 0, 0, "09000064b91a649e"], ["FDA-2026-N-0826-0001", "FDA", "FDA-2026-N-0826", "Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public\nDocket; Request for Comments\u2014 United States (U.S.) 2026\u20132027 Influenza Vaccine Strain Composition", "Notice", "Request for Comments", "2026-02-12T05:00:00Z", 2026, 2, "2026-02-12T05:00:00Z", "2026-03-12T03:59:59Z", "2026-02-28T10:00:15Z", "2026-02787", 1, 0, "09000064b91a649f"], ["FDA-2026-N-0302-0001", "FDA", "FDA-2026-N-0302", "Butylated Hydroxyanisole (BHA); Request for Information", "Notice", "Requests for Information (RFI)", "2026-02-11T05:00:00Z", 2026, 2, "2026-02-11T05:00:00Z", "2026-04-14T03:59:59Z", "2026-02-27T10:00:23Z", "2026-02761", 1, 0, "09000064b91a25bf"], ["FDA-2023-N-5706-0003", "FDA", "FDA-2023-N-5706", "Voluntary Quality Management Maturity Prototype Assessment Protocol Evaluation Program", "Notice", "Announcement", "2026-02-11T05:00:00Z", 2026, 2, "2026-02-11T05:00:00Z", null, "2026-02-11T19:17:34Z", "2026-02768", 0, 0, "09000064b91a26d1"], ["FDA-2025-E-0152-0006", "FDA", "FDA-2025-E-0152", "Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY", "Notice", "Determinations", "2026-02-06T05:00:00Z", 2026, 2, "2026-02-06T05:00:00Z", "2026-08-06T03:59:59Z", "2026-02-06T20:05:43Z", "2026-02388", 1, 0, "09000064b919467e"], ["FDA-2026-D-0207-0001", "FDA", "FDA-2026-D-0207", "E22 General Considerations for Patient Preference Studies; International Council for Harmonisation; Draft\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2026-02-06T05:00:00Z", 2026, 2, "2026-02-06T05:00:00Z", null, "2026-02-06T19:33:49Z", "2026-02324", 0, 0, "09000064b9195d41"], ["FDA-2024-D-2033-0054", "FDA", "FDA-2024-D-2033", "Agency Information Collection Activities; Proposed Collection; Comment Request; Expedited Programs for Serious Conditions\u2014Accelerated Approval of Drugs and Biologics", "Notice", "60 Day Proposed Information Collection", "2026-02-06T05:00:00Z", 2026, 2, "2026-02-06T05:00:00Z", "2026-04-08T03:59:59Z", "2026-02-06T19:55:42Z", "2026-02386", 1, 0, "09000064b9195c65"], ["FDA-2024-E-3536-0006", "FDA", "FDA-2024-E-3536", "Determination of Regulatory Review Period for Purposes of Patent Extension; AURORA EV\u2013ICD", "Notice", "Determinations", "2026-02-06T05:00:00Z", 2026, 2, "2026-02-06T05:00:00Z", null, "2026-02-06T20:29:55Z", "2026-02383", 0, 0, "09000064b9195b55"], ["FDA-2025-E-0153-0006", "FDA", "FDA-2025-E-0153", "Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY", "Notice", "Determinations", "2026-02-06T05:00:00Z", 2026, 2, "2026-02-06T05:00:00Z", "2026-08-06T03:59:59Z", "2026-02-06T20:06:34Z", "2026-02388", 1, 0, "09000064b919467f"], ["FDA-2024-E-3539-0006", "FDA", "FDA-2024-E-3539", "Determination of Regulatory Review Period for Purposes of Patent Extension; BEQVEZ", "Notice", "Determinations", "2026-02-06T05:00:00Z", 2026, 2, "2026-02-06T05:00:00Z", "2026-08-06T03:59:59Z", "2026-02-14T13:19:52Z", "2026-02387", 1, 0, "09000064b9195b4d"], ["FDA-2024-E-3535-0006", "FDA", "FDA-2024-E-3535", "Determination of Regulatory Review Period for Purposes of Patent Extension; AURORA EV\u2013ICD", "Notice", "Determinations", "2026-02-06T05:00:00Z", 2026, 2, "2026-02-06T05:00:00Z", null, "2026-02-06T20:29:21Z", "2026-02383", 0, 0, "09000064b9196229"], ["FDA-2026-N-0232-0001", "FDA", "FDA-2026-N-0232", "Medical Devices; Exemptions From Premarket Notification: Class II Devices; Request for Comments", "Notice", "Request for Comments", "2026-02-06T05:00:00Z", 2026, 2, "2026-02-06T05:00:00Z", "2026-04-08T03:59:59Z", "2026-02-26T10:00:18Z", "2026-02377", 1, 0, "09000064b9195af7"], ["FDA-2025-E-1227-0006", "FDA", "FDA-2025-E-1227", "Determination of Regulatory Review Period for Purposes of Patent Extension; ALFAPUMP", "Notice", "Determinations", "2026-02-06T05:00:00Z", 2026, 2, "2026-02-06T05:00:00Z", "2026-04-08T03:59:59Z", "2026-02-11T02:11:43Z", "2026-02384", 1, 0, "09000064b9195d0d"], ["FDA-2025-N-1956-0002", "FDA", "FDA-2025-N-1956", "Matthew Teltser: Final Debarment Order", "Notice", "General Notice", "2026-02-06T05:00:00Z", 2026, 2, "2026-02-06T05:00:00Z", null, "2026-02-06T20:25:04Z", "2026-02349", 0, 0, "09000064b9195b88"]], "truncated": false, "filtered_table_rows_count": 159, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice", "p2": "2026"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026", "results": [{"value": "FDA", "label": "FDA", "count": 159, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Notice&posted_year=2026", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026", "results": [{"value": "Notice", "label": "Notice", "count": 159, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2026", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026", "results": [{"value": 2026, "label": 2026, "count": 159, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026&_facet=comment_end_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026&_facet_date=last_modified"}], "next": "2026-02-06T05~3A00~3A00Z,FDA-2025-N-1956-0002", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2026&_next=2026-02-06T05~3A00~3A00Z%2CFDA-2025-N-1956-0002&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 418.3343059848994, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}